Loading...

DRUG DESIGN DEVELOPMENT AND DELIVERY JOURNAL (ISSN: 2631-3278)

About the Journal

Recently Published Articles

Research Article

Application of Tramadol Hydrogel as a Transdermal Drug Delivery with Sonophoresis Device to Rats

Corresponding Author: Sitem Merve Sahin, Hacettepe university, Turkey.
Pdf Full text Views (2440)

Research Article

Why Are Bat Molecules More Effective Than Chloroquine and Its Derivatives Against the Covid-19 Epidemic? Opinions and Comments

Corresponding Author: Abdelkader Rahmouni, BP 1524, El’Menouer, 31000 Oran, Algeria.
Pdf Full text Views (2464)

Research Article

The Role of Electron Structure of Polymers at Their Biodegradation in Living Organisms

Corresponding Author: Letfullin RR, Rose-Hulman Institute of Technology, Department of Physics and Optical Engineering, United States.
Pdf Full text Views (2517)

Research Article

Synthesis and in Vitro Anticancer Activity of LCA-AZT Conjugate

Corresponding Author: Hengguang Li, Physics& Material Science Fayetteville State University, Department of Chemistry, Fayetteville, United States.
Pdf Full text Views (2242)

Review Article

Antimicrobial Peptide Surrogates Based on Freidger Lactam

Corresponding Author: Shimon Shatzmiller, Ariel University of Samaria, Department of Biological Chemistry, Ariel, Israel.
Pdf Full text Views (4539)

Editorial Team

The Drug Design, Development and Delivery Journal (DDDD) is an international, peer-reviewed, open access journal published by Boffin Access Limited, dedicated to advancing innovation in pharmaceutical sciences, medicinal chemistry, and drug delivery systems. The journal provides a trusted global platform for researchers, clinicians, pharmacologists, and industry professionals to share novel findings that drive the future of therapeutics.

By integrating molecular design, preclinical development, and advanced delivery technologies, DDDD seeks to accelerate the translation of research into safe, effective, and patient-centered therapies.

Aims and Scope

The Drug Design, Development and Delivery Journal publishes high-quality contributions including original research articles, reviews, short communications, perspectives, and technical notes. Areas of interest include, but are not limited to:

  • Rational drug design, molecular modeling, and computational chemistry

  • Novel drug targets and mechanisms of action

  • High-throughput screening and lead optimization

  • Pharmacokinetics, pharmacodynamics, and ADME studies

  • Nanotechnology, biomaterials, and controlled drug delivery systems

  • Formulation science, biopharmaceutics, and dosage form innovations

  • Targeted drug delivery, gene delivery, and immunotherapeutics

  • Drug resistance, repurposing, and personalized medicine approaches

  • Regulatory science, clinical trial design, and translational medicine

  • Emerging technologies in vaccine development and biologics

Why Publish with DDDD?

  • Comprehensive Scope – Covers the full drug development pipeline from concept to clinical application.

  • Rigorous Peer Review – Submissions undergo strict double-blind peer review by domain experts.

  • Rapid Publication – Accepted articles are published online quickly to ensure timely visibility.

  • Global Readership – Open access ensures worldwide dissemination to researchers, clinicians, and pharmaceutical industries.

  • Multidisciplinary Platform – Bridges chemistry, biology, pharmacology, biotechnology, and clinical sciences.

  • Author Rights – Authors retain copyright under Creative Commons licensing, maximizing use and citation.

  • Enhanced Formats – Articles published in PDF, HTML, and supplementary formats including datasets and graphical abstracts.

Editorial & Ethical Standards

DDDD upholds the highest editorial standards by adhering to COPE and ICMJE guidelines. All submissions are evaluated on originality, scientific quality, and ethical compliance.

Subjects covered by the Drug Design Development and Delivery Journal

  • Rational Drug Design
  • Molecular Docking
  • Novel therapeutic approaches to disease states
  • High-throughput screening
  • Combinatorial chemistry
  • Advances in key compound classes and therapeutic areas
  • Virtual chemistry
  • Pharmaceutical toxicology
  • Molecular Drug Design
  • Molecular Pharmacology
  • Regulatory sciences
  • In Silico Drug Design
  • Physiologically-Based Pharmacokinetic Modelling
  • Retrometabolic Drug Design
  • Structure-Based Drug Design
  • Chemical Biology Drug Design
  • Protein structure prediction and molecular simulation
  • Herbal Drug Development
  • Translational Drug Development
  • Biotechnology and nano-technology
  • Pharmacoepidemiology
  • Drug Discovery Hit to Lead
  • Drug-drug & Drug-Chemical Interactions
  • Compound Management
  • Computer-assisted Drug Design
  • Quantitative Structure Activity Relationships
  • Nano-materials in Drug Designing

Open Access Journals

Abstracting and Indexing

SCINEXI use Crossref Similarity Check for averting plagiarism

Retractions

SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.

If you wish to report a concern regarding any published article, please share the details with us by clicking below:

Send Information

Subscribe to our Newsletter

Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.

Feedback

At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.

Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com